E3 ubiquitin-protein ligase HUWE1
ARF-binding protein 1 (757-766) is a synthetic peptide corresponding to amino acid residues 757 to 766 of the ARF-binding protein 1 sequence. As a defined peptide fragment, it serves as a valuable molecular tool for dissecting protein-protein interactions involving ARF-binding proteins, which are critical regulators of vesicular trafficking and signal transduction pathways. The precise sequence and biochemical properties of this peptide facilitate targeted studies on the structural and functional domains of ARF-binding protein 1, providing researchers with a means to probe the molecular underpinnings of cellular transport mechanisms and related regulatory networks.
Protein-protein interaction studies: The ARF-binding protein 1 (757-766) peptide is frequently utilized to investigate the specific binding interfaces between ARF-binding protein 1 and its interacting partners. By employing this peptide in affinity assays, pull-down experiments, or competition binding studies, researchers can map critical contact points within larger protein complexes. Such applications help elucidate the mechanistic basis of ARF-mediated signaling events, advancing the understanding of how ARF-binding proteins coordinate intracellular trafficking and membrane dynamics.
Signal transduction pathway analysis: As a functional motif derived from ARF-binding protein 1, this peptide can be employed in cell-free or cellular assays to modulate or monitor the activity of downstream signaling cascades. By introducing the peptide into experimental systems, investigators can assess its capacity to disrupt or mimic native protein interactions, thereby uncovering the role of the 757-766 region in the regulation of ARF-dependent pathways. This approach is particularly valuable for delineating the contribution of discrete protein segments to cellular signaling fidelity.
Epitope mapping and antibody characterization: The defined sequence of ARF-binding protein 1 (757-766) makes it an ideal reagent for epitope mapping studies. Researchers can use the peptide to identify and characterize antibodies that specifically recognize this region, facilitating the development of high-affinity immunoreagents for detection or quantification of ARF-binding protein 1 in various biological samples. Such applications are crucial for advancing both basic research and the development of analytical tools targeting vesicular transport proteins.
Peptide-based inhibitor screening: In drug discovery and biochemical research, the ARF-binding protein 1 (757-766) peptide may serve as a template or reference for the design and screening of small molecule inhibitors or peptide mimetics. By evaluating the binding affinity of candidate compounds to the peptide or its interacting partners, scientists can identify molecules capable of modulating ARF-binding protein 1 function. This strategy supports the search for novel modulators of vesicular trafficking and related cellular processes.
Structural and biophysical studies: The well-defined nature of the ARF-binding protein 1 (757-766) fragment enables its use in structural biology applications, such as nuclear magnetic resonance (NMR) spectroscopy or crystallography, to resolve the conformational properties of this region. Incorporating the peptide into structural analyses provides insights into its secondary structure, dynamics, and potential interaction surfaces, thereby contributing to a more comprehensive understanding of ARF-binding protein 1 architecture and its mechanistic roles in cellular physiology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More